Advertisement

Latest News

Cocoa Shows Limited Benefit for Reducing Macular Degeneration Risk

17 minutes ago

Cocoa flavanols can be helpful over a brief period, but after 2 years there is little benefit to risk of age-related macular degeneration.

Identifying Unique Health Challenges of AAPI Populations, with Adrienne Poon, MD, MPH

2 hours ago

Poon discussed a community health needs survey and how the “model minority” myth can impact care for Asian Americans.

FDA Approves Inebilizumab (Uplizna) as First IgG4-RD Therapy for Adults

3 hours ago

Regulatory approval of inebilizumab for immunoglobulin G4-related disease (IgG4-RD) marks the first and only available treatment for adults.

VTEs with JAK Inhibitors Similar Between Those with Atopic Dermatitis, General Population

5 hours ago

These findings, while reassuring for JAK inhibitor prescription, nonetheless suggest that VTE-related recommendations for prescriptions should be maintained.

Q1 2025 Recap: Allergy

6 hours ago

Q1 2025 allergy updates: FDA approved the first omalizumab biosimilar, and experts shared insights on peanut immunotherapy and food allergy treatments.

Advertisement
Advertisement